Vol. 26, No. 8 (2014) Asymmetric Synthesis and Stereoselectivity of 1-{2-[(1R,2S)-2-(Chloromethyl)cyclopropyl]ethyl}-4-methoxybenzene 2439
2977, 2924, 2852 (sp3 C-H stretch), 1511, 1456 (sp2 C=C
stretch), 1243, 1175, 1142 (sp3 C-O stretch), 846, 822, 670
(sp2 C-H oop bending).
Synthesis of 2-(1-(4-methoxyphenyl)hex-5-en-3-yl)-
4,4,5,5-tetramethyl-1,3,2-dioxaborolane (7): Racemic 2-(1-
(4-methoxyphenyl)hex-5-en-3-yl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (7) was prepared by substituting (-)sparteine
by N,N,N,N-tetramethylethylenediamine (TMEDA) (1.22 mL,
8.18 mmol, 1.2 eq.) (5b) (Fig. 3).
added at -40 °C and the reaction mixture was allowed to warm
to room temperature (Fig. 4). EtOAc was dded and the layers
were separated. The aqueous phase was extracted with EtOAc,
the organic layers were combined, washed with brine, dried
(MgSO4), concentrated. The crude mixture was finally purified
by column chromatography (SiO2, 99:1 Pentane/EtOAc) to
give desired 1-(2-((1R,2S)-2-(chloromethyl)cyclopropyl)-
ethyl)-4-methoxybenzene (9) as colorless oil (0.025 g, 49 %).
1H NMR (400 MHz, CDCl3) δ ppm 7.12 (2H, d, J = 8.31 Hz,
2 × ArH) 6.83 (2H, d, J = 8.80 Hz, 2 × ArH) 3.79 (3H, s,
OCH3) 3.69 (0.7H, dd, J = 11.25, 7.09 Hz, major CHHCl)
3.49-3.34 (0.3 H, minor CHHCl, 1H, m, CHHCl) 2.71 (1H, t,
J = 7.83 Hz, ArCHHCH2CH) 2.66 (1H, t, J = 7.70 Hz,
ArCHHCH2CH) 1.81-1.71 (0.7 H, m, major ArCH2CHHCH)
1.65-1.43 (0.3H, minor ArCH2CHHCH, 1H, m, ArCH2CH-
HCH) 1.33-1.22 (0.7H, m, major CH(CH2)CHCH2Cl) 1.06-
0.95 (0.3H, minor CH(CH2)CHCH2Cl, 0.7H, m, CH(CH2)CH-
CH2Cl) 0.88-0.81 (0.3H, m, CH(CHH)CHCH2Cl) 0.79-0.70
(0.3H, m, CH(CH2)CHCH2Cl) 0.54-0.46 (1H, m, CH(CHH)-
CHCH2Cl) 0.06 (0.7H, q, J = 5.54 Hz, CH(CHH)CHCH2Cl).
13C NMR (100 MHz, CDCl3) δ ppm 157.77 (1C, major, ArC),
157.71 (1C, minor,ArC), 134.25 (1C, major,ArC), 134.21 (1C,
minor,ArC), 129.32 (1C, major,ArC), 113.72 (1C, minor,ArC),
113.69 (1C, major,ArC), 55.26 (1C, major, OCH3), 55.24 (1C,
minor, OCH3), 50.22 (1C, minor, CH2Cl), 46.65 (1C, major,
CH2Cl), 35.63 (1C, minor, CH2CH2CH(CH2)CH-CH2Cl),
35.26 (1C, major, CH2CH2CH(CH2)CHCH2Cl), 34.69
(1C, minor, CH2CH2CH(CH2)CHCH2Cl), 30.54 (1C, major,
CH2CH2CH(CH2)CHCH2Cl), 21.34 (1C, minor, CH2CH2CH-
(CH2)CHCH2Cl), 19.83 (1C, minor, CH2CH2CH(CH2)CH-
CH2Cl), 18.54 (1C, major, CH2CH2CH(CH2)CHCH2Cl), 17.72
(1C, major, CH2CH2CH(CH2)CHCH2Cl), 12.93 (1C, minor,
CH2CH2CH(CH2)CHCH2Cl), 12.11 (1C, major, CH2CH2CH
(CH2)CHCH2Cl). IR (film): ν (cm-1) 3026 (sp2 C-H stretch),
2977, 2930, 2855, 2835 (sp3 C-H stretch), 1510, 1455 (sp2
C=C stretch), 1242, 1176, 1035 (sp3 C-O stretch), 822, 696,
575 (sp3 C-Cl stretch). HRMS (ESI) calcd. for C13H17OCl
[M+H]+ 225.1039, found 225.1039. [α]D +3.84 (c 0.52, CDCl3)
SFC separation conditions: Chiralpak IA column with
guard, 5 % iPrOH in hexane, flow rate: 2 mL/min, 39.9 °C; tR
Pure sec-boronic ester (7) was collected as colorless oil
(1.62g, 75.3 %). 1H NMR (400 MHz, CDCl3) δ ppm 7.09 (2H,
d, J = 8.80 Hz, 2 × ArH) 6.81 (2H, d, J = 8.80 Hz, 2 × ArH)
5.86-5.75 (1H, m, CH=CH2) 5.04 (1H, d, J = 2.20 Hz,
CH=CHH) 4.94 (1H, d, J = 10.27 Hz, CH=CHH) 3.78 (3H, s,
OCH3) 2.63-2.48 (2H, m, ArCH2CH2CHBCH2) 2.27-2.11 (2H,
m, ArCH2CH2CHBCH2) 1.78-1.58 (2H, m, ArCH2CH2CHB-
CH2) 1.25 (12H, s, 4 × CH3) 1.08-1.18 (1H, m,ArCH2CH2CH-
BCH2) 13C NMR (100 MHz, CDCl3) δ ppm 157.6 (1C, -OCH3),
138.4 (2C, 2 ×ArCH), 135.0 (2C, 2 ×ArCH), 129.2 (1C,ArC-
O), 114.9 (1C, -CH2CH=CH2), 113.6 (1C, -CH=CH2), 83.0
(2C, 2 × C(CH3)2), 55.2 (1C, ArCCH2), 35.3 (1C, -CH2CH2-
CHB), 34.5 (1C, -CH2CHB), 33.1 (1C, -CHBCH2CH), 24.9
(1C, -CH2CH2CHB), 24.8 (4C, 2 × (CH3)2C). 11B NMR (96.23
MHz, None) δ ppm 33.24. IR (film): ν(cm-1) 3390 (O-H
stretch), 3001 (sp2 C-H stretch), 2931, 2835 (sp3 C-H stretch),
1511, 1441 (sp2 C=C stretch), 1244, 1177, 1036 (sp3 C-O
stretch), 915, 822 (sp2 C-H oop bending).
Synthesis of 1-(2-((1R,2S)-2-(chloromethyl)cyclopropyl)-
ethyl)-4-methoxybenzene (9): To a solution of 1,3-bis(trifluoro-
methyl)-5-bromobenzene (0.08 g, 0.274 mmol, 1.2 eq) (6a)
in THF (2.4 mL) at -78 °C was added n-BuLi (1.6 M in hexane,
0.17 mL, 0.274 mmol, 1.2 eq.) dropwise. The mixture was
stirred 1 h at -78 °C before a solution of boronic ester (0.072 g,
0.228 mmol, 1.0 eq.) (6) in THF (1.2 mL) was added dropwise.
The reaction mixture was stirred for 0.5 h at -78 °C and 0.5 h
at room temperature to give the boronate complex solution
(8). The reaction mixture was cooled to -40 °C, a solution of
TCCA (0.064 g, 0.274 mmol, 1.2 eq.) (8a) in MeCN (1.2 mL)
was then added dropwise over 1min and the reaction mixture
was stirred for 5 min at -40 °C. 20 % Na2S2O3 (3 mL) was
O
O
O
B
s-BuLi
(5b)
O
B
TMEDA
O
N
+
O
Et2O
O
(7)
O
(5)
Fig. 3. Synthesis of 2-(1-(4-methoxyphenyl)hex-5-ene-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
(4)
CF3
F3C
n-BuLi
O
B
O
O
O
(6a)
3,5-(CF3)2C6H3Br
B
Cl
TCCA (8a)
Li
THF, -78oC
MeCN, -40oC, 5min
(9)
O
O
(6)
(8)
O
Fig. 4. Synthesis of 1-(2-((1R,2S)-2(chloromethyl)cyclopropyl)ethyl)-4-methoxybenzene